Healthcare
Live Price
Offline$55.40
+0.72% today
1Y Change
+19.04%
Window
Jun 26, 2025 → Jun 23, 2026
Coverage: 248 bars · Jun 26, 2025 → Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Bristol-Myers Squibb Co (BMY) is a Healthcare stock with a market cap of $116.28B. The stock last traded around $55.40 and up 19.0% across the available one-year price window (Jun 26, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of -0.2%, EPS growth of +178.7%, a dividend yield of 4.4%. What stands out right now is revenue -0.2%, EPS +178.7%, free cash flow -7.9% with operating margin 28.5% and ROIC 13.5%. The dividend matters to the case here, with a current yield around 4.4%. Valuation is more restrained than many high-expectation growth names at P/E 16.0 and price/sales 2.4. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines BMY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BMY
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BMY Max Drawdown
-13.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BMY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
-0.2%
EPS Growth
+178.7%
Gross Margin
71.1%
Net Margin
14.6%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.